Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter Study Evaluating Quality of Life in Patients With Advanced Malignant Tumors With or Without "add-on" Homeopathy
The EORTC-QLQ-C30 as well as a VAS scale for subjective well-being will be filled out by the
patients.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
Life quality
Life quaity is evaluated by using the results of the EORTC-QLQ-C30 questionnaire
7 years
No
Michael Frass, Prof. Dr.
Principal Investigator
Medical University Vienna
Austria: Agency for Health and Food Safety
5
NCT01509612
January 2011
January 2019
Name | Location |
---|